Determinants of health-related quality of life in multiple sderosis: the role of illness intrusiveness.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMID 12166502)

Published in Mult Scler on August 01, 2002

Authors

M A Shawaryn1, K M Schiaffino, N G LaRocca, M V Johnston

Author Affiliations

1: Kessler Medical Rehabilitation Research and Education Corporation, West Orange, New Jersey 07052, USA. mshawaryn@kmrrec.org

Articles by these authors

(truncated to the top 100)

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol (1989) 13.32

Fatigue in multiple sclerosis. Arch Neurol (1988) 2.77

Invited article: The ABPN maintenance of certification program for neurologists: past, present, and future. Neurology (2008) 2.31

Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Brain Res Rev (1990) 2.27

Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr (1992) 1.82

A randomized efficacy and feasibility study of imagery in acute stroke. Clin Rehabil (2001) 1.67

Social support as a double-edged sword: the relation of positive and problematic support to depression among rheumatoid arthritis patients. Soc Sci Med (1991) 1.66

Increased intracerebral excitatory amino acids and nitric oxide after hypothermic circulatory arrest. Ann Thorac Surg (1999) 1.65

Mental practice combined with physical practice for upper-limb motor deficit in subacute stroke. Phys Ther (2001) 1.57

Selective vulnerability in the neonatal brain. Ann Neurol (1998) 1.52

Pharmacologically induced preconditioning with diazoxide: a novel approach to brain protection. Ann Thorac Surg (2001) 1.50

Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci (2000) 1.49

Religiosity and sexual risk-taking behavior during the transition to college. J Adolesc (2000) 1.47

Choline acetyltransferase activity in striatum of neonatal rats increased by nerve growth factor. Science (1985) 1.41

Diffusion tensor imaging in children with periventricular leukomalacia: variability of injuries to white matter tracts. AJNR Am J Neuroradiol (2007) 1.40

High-dose oral baclofen: experience in patients with multiple sclerosis. Neurology (1991) 1.40

Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience (2004) 1.36

Self-care self-efficacy, quality of life, and depression after stroke. Arch Phys Med Rehabil (2000) 1.31

Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Brain Res (1986) 1.30

Evidence for a cholinergic projection to neocortex from neurons in basal forebrain. Proc Natl Acad Sci U S A (1979) 1.27

Guidelines for neuropsychological research in multiple sclerosis. Arch Neurol (1990) 1.24

Brain magnetic resonance imaging in suspected extrapyramidal cerebral palsy: observations in distinguishing genetic-metabolic from acquired causes. J Pediatr (1997) 1.24

Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler (1999) 1.23

Outcome measures in spinal cord injury: recent assessments and recommendations for future directions. Spinal Cord (2009) 1.23

Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res (1988) 1.21

Histological and neurochemical effects of fetal treatment with methylazoxymethanol on rat neocortex in adulthood. Brain Res (1979) 1.21

A prospective study of depression and immune dysregulation in multiple sclerosis. Arch Neurol (1992) 1.20

Diffusion tensor imaging of periventricular leukomalacia shows affected sensory cortex white matter pathways. Neurology (2002) 1.19

Modified constraint induced therapy: a randomized feasibility and efficacy study. J Rehabil Res Dev (2001) 1.16

Nitric oxide mediates neurologic injury after hypothermic circulatory arrest. Ann Thorac Surg (1999) 1.16

A study of fatigue in systemic lupus erythematosus. J Rheumatol (1990) 1.13

Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol (1999) 1.12

Predictors of dysphagia after spinal cord injury. Arch Phys Med Rehabil (1999) 1.10

Hematological monitoring during therapy with carbamazepine in children. Ann Neurol (1983) 1.09

Neocortical cholinergic innervation: a description of extrinsic and intrinsic components in the rat. Exp Brain Res (1981) 1.04

Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Ann Behav Med (1997) 1.04

Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett (1990) 1.03

Cerebrospinal fluid monoamine metabolites in patients with infantile spasms. Neurology (1984) 1.02

Development of amino acid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol (1999) 1.01

Functional outcome of hemorrhagic and nonhemorrhagic stroke patients after in-patient rehabilitation. Am J Phys Med Rehabil (1996) 1.01

Neonatal lead exposure impairs development of rodent barrel field cortex. Proc Natl Acad Sci U S A (2000) 1.01

Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy. Ann Neurol (1991) 0.99

Model of Wernicke's encephalopathy. Arch Neurol (1981) 0.98

Glutamate excitotoxicity: a mechanism of neurologic injury associated with hypothermic circulatory arrest. J Thorac Cardiovasc Surg (1994) 0.98

Brief post-hypoxic-ischemic hypothermia markedly delays neonatal brain injury. Brain Dev (1997) 0.97

Quantitative assessment of neuroprotection against NMDA-induced brain injury. Exp Neurol (1989) 0.97

Neuroimaging studies in Rett syndrome. Brain Dev (2001) 0.96

Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxia. Neuroscience (2007) 0.96

Neurologic injury in cardiac surgical patients with a history of stroke. Ann Thorac Surg (1996) 0.96

MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur J Pharmacol (1987) 0.96

Periventricular leukomalacia: relationship between lateral ventricular volume on brain MR images and severity of cognitive and motor impairment. Radiology (2000) 0.95

Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen. Neuron (1989) 0.95

Cost-benefits of medical rehabilitation: review and critique. Arch Phys Med Rehabil (1983) 0.95

Characterization and regional distribution of strychnine-insensitive [3H]glycine binding sites in rat brain by quantitative receptor autoradiography. Neuroscience (1990) 0.95

Rehabilitation of intimacy and sexual dysfunction in couples with multiple sclerosis. Mult Scler (2001) 0.93

Trimodal evoked potentials compared with magnetic resonance imaging in the diagnosis of multiple sclerosis. Arch Neurol (1987) 0.93

Neuronal nitric oxide synthase inhibition reduces neuronal apoptosis after hypothermic circulatory arrest. Ann Thorac Surg (1997) 0.92

Shoulder pain and subluxation after stroke: correlation or coincidence? Am J Occup Ther (1996) 0.92

Competence in discourse as a measure of social integration and quality of life in persons with traumatic brain injury. Brain Inj (1998) 0.92

Role of glutamate receptor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model. Exp Neurol (1998) 0.92

Potential use of nerve growth factor to treat Alzheimer's disease. Neurobiol Aging (1989) 0.91

Efficacy of stress-inoculation training in coping with multiple sclerosis. J Consult Clin Psychol (1987) 0.90

Right-sided brain lesions in infants following extracorporeal membrane oxygenation. Pediatrics (1988) 0.90

Relative contributions of spousal support and illness appraisals to depressed mood in arthritis patients. Arthritis Care Res (1995) 0.89

Excitatory amino acid neurotoxicity in the developing brain. NIDA Res Monogr (1993) 0.89

10.5-eV photoionization mass spectrometry of aliphatic compounds. J Am Soc Mass Spectrom (1990) 0.89

Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain. Stroke (1986) 0.89

Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J Pediatr (1998) 0.88

RNA editing of a human glutamate receptor subunit. Brain Res Mol Brain Res (1994) 0.88

Methylazoxymethanol treatment of fetal rats results in abnormally dense noradrenergic innervation of neocortex. Science (1979) 0.88

Lesch-Nyhan syndrome: CSF neurotransmitter abnormalities. Neurology (1985) 0.87

Prevalence and identification of problems in daily functioning in a primary medicine clinic. Disabil Rehabil (2000) 0.87

Expression of NMDA receptor subunit mRNA after MK-801 treatment in neonatal rats. Brain Res Dev Brain Res (1998) 0.87

Effects of hypoxia-ischemia on monoamine metabolism in the immature brain. Ann Neurol (1984) 0.87

Ontogeny of non-NMDA glutamate receptors in rat barrel field cortex: I. Metabotropic receptors. J Comp Neurol (1997) 0.86

Ontogeny of neurochemical markers for noradrenergic, GABAergic, and cholinergic neurons in neocortex lesioned with methylazoxymethanol acetate. J Neurochem (1980) 0.86

Cognitive impairment in Coffin-Lowry syndrome correlates with reduced RSK2 activation. Neurology (2001) 0.85

Pathogenesis of hypoxic-ischemic brain injury in a perinatal rodent model. Neurosci Lett (1984) 0.84

Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev (2001) 0.84

Assessing the impact of cerebral injury after cardiac surgery: will determining the mechanism reduce this injury? Ann Thorac Surg (1999) 0.84

Differential ontogenic development of three receptors comprising the NMDA receptor/channel complex in the rat hippocampus. Exp Neurol (1990) 0.84

Hypoxia-ischemia produces focal disruption of glutamate receptors in developing brain. Brain Res (1987) 0.84

Temporal shift in methyl-CpG binding protein 2 expression in a mouse model of Rett syndrome. Neuroscience (2006) 0.84

Brain neurotransmitters and neuromodulators in pediatrics. Pediatrics (1982) 0.83

Evidence for transient perinatal glutamatergic innervation of globus pallidus. J Neurosci (1987) 0.83

Ontogeny of non-NMDA glutamate receptors in rat barrel field cortex: II. Alpha-AMPA and kainate receptors. J Comp Neurol (1997) 0.83

Application of the ART-2a algorithm to laser ablation aerosol mass spectrometry of particle standards. Anal Chem (2001) 0.83

Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats. Neuroscience (1990) 0.83

Neurotransmitter alterations in a model of perinatal hypoxic-ischemic brain injury. Ann Neurol (1983) 0.83

Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development. Brain Res (1992) 0.83

MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats. Neuroscience (1990) 0.83

AMPA glutamate receptor antagonism reduces neurologic injury after hypothermic circulatory arrest. Ann Thorac Surg (1995) 0.82

The glutamate analogue quisqualic acid is neurotoxic in striatum and hippocampus of immature rat brain. Neurosci Lett (1986) 0.82

The ontogeny of glutamate receptors in rat barrel field cortex. Brain Res Dev Brain Res (1995) 0.82

Field testing of a minimal record of disability in multiple sclerosis: the United States and Canada. Acta Neurol Scand Suppl (1984) 0.82

Oligonucleotide sequence and composition determined by matrix-assisted laser desorption/ionization. Anal Chem (1996) 0.82

Glutamate recognition sites in human fetal brain. Neurosci Lett (1988) 0.81

Neuroprotective effects of MK-801, TCP, PCP and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model. Brain Res (1989) 0.81

Hypoxic-ischemic brain injury in the newborn. Cellular mechanisms and potential strategies for neuroprotection. Clin Perinatol (1997) 0.81

Perinatal hypoxia-ischemia disrupts striatal high-affinity [3H]glutamate uptake into synaptosomes. J Neurochem (1986) 0.81